Dissecting DELIVER: Dosing, Non-Polymer Binding Implicated In Guidant Trial
This article was originally published in The Gray Sheet
Executive Summary
The role of insufficient dosing in the DELIVER trial evaluating Guidant's Achieve drug-eluting stent will likely emerge in presentations at the American College of Cardiology's annual meeting in Chicago March 30-April 2